<?xml version="1.0" encoding="UTF-8"?>
<ref id="B171-antioxidants-09-01048">
 <label>171.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Helal</surname>
    <given-names>N.A.</given-names>
   </name>
   <name>
    <surname>Eassa</surname>
    <given-names>H.A.</given-names>
   </name>
   <name>
    <surname>Amer</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Eltokhy</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Edafiogho</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Nounou</surname>
    <given-names>M.I.</given-names>
   </name>
  </person-group>
  <article-title>Nutraceuticalsâ€™ novel formulations: The good, the Bad, the unknown and patents involved</article-title>
  <source>Recent Pat. Drug Deliv. Formul.</source>
  <year>2019</year>
  <volume>13</volume>
  <fpage>105</fpage>
  <lpage>156</lpage>
  <pub-id pub-id-type="doi">10.2174/1872211313666190503112040</pub-id>
  <pub-id pub-id-type="pmid">31577201</pub-id>
 </element-citation>
</ref>
